Veracyte, Inc. VCYT
NASDAQ
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 0.95% | 8.09% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.95% | 8.09% | |||
| Cost of Revenue | 6.47% | 0.52% | |||
| Gross Profit | -0.75% | 10.66% | |||
| SG&A Expenses | 1.03% | 16.75% | |||
| Depreciation & Amortization | 16.60% | -3.77% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.82% | 9.38% | |||
| Operating Income | -20.50% | 1.47% | |||
| Income Before Tax | -20.36% | -11.51% | |||
| Income Tax Expenses | -1,104.94% | -18.47% | |||
| Earnings from Continuing Operations | 23.59% | -11.21% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 23.59% | -11.21% | |||
| EBIT | -20.50% | 1.47% | |||
| EBITDA | -12.83% | -0.92% | |||
| EPS Basic | 22.78% | -11.69% | |||
| Normalized Basic EPS | -14.52% | -11.97% | |||
| EPS Diluted | 22.58% | -11.43% | |||
| Normalized Diluted EPS | -14.70% | -12.33% | |||
| Average Basic Shares Outstanding | 0.66% | 0.55% | |||
| Average Diluted Shares Outstanding | 0.88% | 0.92% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||